Agenus Inc.
Quick facts
Phase 3 pipeline
- HSPPC-96 or Oncophage · Oncology
HSPPC-96 is a personalized cancer vaccine that uses heat shock protein-peptide complexes derived from a patient's own tumor to stimulate immune recognition and destruction of cancer cells.
Phase 2 pipeline
- AGEN1884
- Balstililmab · Other
- HerpV and QS-21 · Oncology
Stimulates the immune system by activating CD4+ T cells through the QS-21 adjuvant
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Agenus Inc.
What is Agenus Inc.'s pipeline?
Agenus Inc. has 1 drugs in Phase 3, 3 in Phase 2, 3 in Phase 1. Late-stage candidates include HSPPC-96 or Oncophage.
Related
- Sector hub: All tracked pharma companies